Bio-IT World Conference Awards Gene Logic's ASCENTA System As 'Best of Show'.Business Editors/Health/Medical Writers BIOWIRE2K BioITWorld Boston 2004 GAITHERSBURG, Md.--(BUSINESS WIRE)--April 5, 2004 Breakthrough Gene Expression Discovery System Honored for Innovation in Informatics Same as information technology and information systems. The term is more widely used in Europe. Tools & Data Gene Logic Inc. (Nasdaq:GLGC) announced today that its ASCENTA(TM) System received top honors as "Best of Show" in the category of Informatics Tools and Data at the IDG IDG International Data Group IDG Integrated Drive Generator IDG Installation Design Guide IDG Internet Discussion Group IDG Inset Dielectric Guide IDG International Dangerous Goods (mail, shipping) Bio-IT World Conference and Expo last week in Boston. The ASCENTA System was voted Best of Show by a joint team of Bio-IT World and Health-IT World magazine editors and leading industry experts. Best of Show awards recognize new products demonstrating exceptional technology innovations across the life sciences drug discovery process, healthcare management and outcomes-based medicine. "Gene Logic's presentation brought to life the ASCENTA System as it would operate in a clinical research setting and its potential for enabling drug discovery and development research," said John Russell John Russell may refer to:
"Exhibiting at the Bio-IT World Conference and Expo is crucial to bringing our gene expression information tools to the right life sciences professionals," said Mark D. Gessler, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Gene Logic Inc. "Being recognized for the innovation of the ASCENTA System at this venue is outside validation of its value for clinical researchers." International Data Group (IDG) publishes more than 300 key magazines and newspapers for the technology sector as well as more than 400 Web sites worldwide. As the industry's premier event showcasing new technologies for life sciences, Bio-IT World Conference and Expo attracts professionals and decision makers across the pharmaceutical and biotechnology sectors. For a copy of the press release issued by Bio-IT World, Inc. related to the Best of Show Awards for 2004, please proceed to: http://www.bio-itworld.com/pressroom. About the ASCENTA System The ASCENTA System provides a unique information source of microarray gene expression profiles from a broad range of clinically relevant disease and normal tissue samples from humans and animal disease models. The profiles comprise approximately 9,000 human, rat and mouse samples curated into nearly 1,000 sample sets by experienced pathologists and molecular biologists and provide difficult to obtain disease and normal sample sets relevant to key therapeutic areas of interest. Gene Logic's ASCENTA System provides a fast, easy, and affordable way to assess, prioritize, and qualify gene targets for clinicians. The intuitive, powerful, highly visual gene expression data-analysis system facilitates rapid and intuitive target prioritization and discovery. Gene Logic Overview Gene Logic is a pharmacogenomics-driven solutions and service provider to pharmaceutical and biotechnology researchers worldwide. Gene Logic's unique combination of expertise in genomics information and classical preclinical preclinical /pre·clin·i·cal/ (-klin´i-k'l) before a disease becomes clinically recognizable. pre·clin·i·cal adj. 1. study design, are focused on enabling improved drug pipeline productivity through enhancing the predictive value pre·dic·tive value n. The likelihood that a positive test result indicates disease or that a negative test result excludes disease. predictive value a measure used by clinicians to interpret diagnostic test results. of basic research and increasing pharmaceutical product development success rates. Gene Logic also is working with scientists at the U.S. Food and Drug Administration, Center for Drug Evaluation and Research The Center for Drug Evaluation and Research is a division of the FDA that deals with the approval of drugs. CDER reviews New Drug Applications to ensure that the drugs are safe and effective. It is one of five Centers at the United States Food and Drug Administration. (CDER CDER Center for Drug Evaluation and Research (US FDA) CDER Centre de Développement des Energies Renouvelables (French) CDER Client Development and Evaluation Report ) under a collaborative agreement to develop metrics for quality evaluation and normalization In relational database management, a process that breaks down data into record groups for efficient processing. There are six stages. By the third stage (third normal form), data are identified only by the key field in their record. of microarray data and to develop standards for submission of microarray data as part of CDER's study of the application of genomic technologies in the regulatory approval process. For more information, visit www.genelogic.com or call toll-free - 1/800/GENELOGIC. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion